Trials / Completed
CompletedNCT00271401
A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With Abciximab
A Multicenter, Randomized Trial Evaluating 30-day and 6-month Clinical Outcomes With Three Different Treatment Strategies (Coronary Angioplasty + Abciximab, Intracoronary Stent + Abciximab, and Intracoronary Stent + Placebo) in Patients Undergoing Percutaneous Coronary Intervention
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 2,399 (actual)
- Sponsor
- Centocor, Inc. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effectiveness and safety of intracoronary stenting with or without abciximab, an anti-platelet therapy, and conventional coronary angioplasty with abciximab in patients undergoing percutaneous coronary intervention.
Detailed description
This is a multicenter, randomized, double-blind, placebo-controlled study evaluating the safety and effectiveness of intracoronary stenting with or without abciximab, an anti-platelet therapy, and conventional coronary angioplasty with abciximab in patients undergoing percutaneous coronary intervention. Patients will be randomly assigned to one of three treatment groups: coronary angioplasty plus abciximab, intracoronary stent plus abciximab, or intracoronary stent plus placebo. The primary measures of effectiveness will be a 30-day composite, clinical outcome as determined by the number of deaths, myocardial infarctions, or urgent repeat revascularizations. Please see attached results. Patients will receive one of three different treatments: Coronary angioplasty plus abciximab; Intracoronary stent plus abciximab; or Intracoronary stent plus placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Angioplasty | |
| OTHER | Intracoronary Stent | |
| DRUG | Abxicimab | |
| DRUG | Heparin | |
| DRUG | Placebo |
Timeline
- Start date
- 1996-07-01
- Primary completion
- 1997-09-01
- Completion
- 1997-09-01
- First posted
- 2006-01-02
- Last updated
- 2015-05-25
Source: ClinicalTrials.gov record NCT00271401. Inclusion in this directory is not an endorsement.